Peter Graham is a seasoned global commercial and market access leader currently serving as the Director of Market Access for EMEA at argenx. With extensive experience across diverse healthcare markets, Peter has successfully led market access strategies for rare diseases, most recently focusing on pricing, reimbursement, and policy activities across multiple countries. Previously, Peter held significant roles at Gilead Sciences and Actelion Pharmaceuticals, showcasing expertise in strategic planning and operational excellence. Peter’s educational background includes advanced leadership training from notable institutions such as London Business School and IMD Lausanne. Additionally, Peter is a certified canicross trainer, promoting fitness and well-being through dynamic outdoor activities.
This person is not in the org chart
This person is not in any teams
This person is not in any offices